Literature DB >> 1576174

Regional cerebral blood flow in patients with schizophrenia. A preliminary report.

Y Kawasaki1, M Suzuki, Y Maeda, K Urata, N Yamaguchi, H Matsuda, K Hisada, M Suzuki, T Takashima.   

Abstract

Regional cerebral blood flow was evaluated using Tc99m-HMPAO SPECT in 10 medicated patients with schizophrenia and 9 healthy volunteers. There were no prefrontal regions in the patient group with lower regional indices than in the control group. However, in the left hippocampal region, relative blood flow was significantly increased in the patient group compared with the control group. Furthermore, there was a relative increase in blood flow in the left basal ganglia of the patient group. A negative correlation coefficient was calculated between the relative blood flow in the left middle prefrontal cortex and the severity of the blunted affect, as well as between the relative blood flow in the left basal ganglia and the severity of the anhedonia-asociality. These findings indicate that prefrontal hypoactivity is not invariably present in all schizophrenics and that left basal ganglial hyperactivity may be associated with the effects of antipsychotic treatment and clinical improvement. Moreover, the left hippocampal hyperactivity may correspond to left limbic dysfunction in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576174     DOI: 10.1007/bf02190252

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  21 in total

1.  Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function.

Authors:  R G Paulman; M D Devous; R R Gregory; J H Herman; L Jennings; F J Bonte; H A Nasrallah; J D Raese
Journal:  Biol Psychiatry       Date:  1990-02-15       Impact factor: 13.382

2.  Regional brain function in hallucinations: a study of regional cerebral blood flow with 99m-Tc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations, and normal controls.

Authors:  M Musalek; I Podreka; H Walter; E Suess; V Passweg; D Nutzinger; R Strobl; O M Lesch
Journal:  Compr Psychiatry       Date:  1989 Jan-Feb       Impact factor: 3.735

3.  Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping.

Authors:  M M Singh; S R Kay; L A Opler
Journal:  Psychol Med       Date:  1987-02       Impact factor: 7.723

Review 4.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

5.  Lateralized temporal-limbic dysfunction and psychopathology.

Authors:  P Flor-Henry
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

6.  Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system.

Authors:  L Sokoloff
Journal:  Fed Proc       Date:  1981-06

7.  Neurophysiological aspects of auditory hallucinations. 99mTc-(HMPAO)-SPECT investigations in patients with auditory hallucinations and normal controls--a preliminary report.

Authors:  M Musalek; I Podreka; E Suess; D Nutzinger; V Passweg; R Strobl; H Walter; C Baumgartner; O M Lesch
Journal:  Psychopathology       Date:  1988       Impact factor: 1.944

8.  Negative v positive schizophrenia. Definition and validation.

Authors:  N C Andreasen; S Olsen
Journal:  Arch Gen Psychiatry       Date:  1982-07

9.  Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

Authors:  M S Buchsbaum; J C Wu; L E DeLisi; H H Holcomb; E Hazlett; K Cooper-Langston; R Kessler
Journal:  Biol Psychiatry       Date:  1987-04       Impact factor: 13.382

10.  Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.

Authors:  R D Neirinckx; L R Canning; I M Piper; D P Nowotnik; R D Pickett; R A Holmes; W A Volkert; A M Forster; P S Weisner; J A Marriott
Journal:  J Nucl Med       Date:  1987-02       Impact factor: 10.057

View more
  25 in total

1.  Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.

Authors:  Liam J Drew; Kimberly L Stark; Karine Fénelon; Maria Karayiorgou; Amy B Macdermott; Joseph A Gogos
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

Review 2.  Hippocampal function, declarative memory, and schizophrenia: anatomic and functional neuroimaging considerations.

Authors:  Alison R Preston; Daphna Shohamy; Carol A Tamminga; Anthony D Wagner
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

Review 3.  Isolating pathogenic mechanisms embedded within the hippocampal circuit through regional vulnerability.

Authors:  Scott A Small
Journal:  Neuron       Date:  2014-10-01       Impact factor: 17.173

Review 4.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

5.  A quantitative magnetic resonance imaging study of patients with schizophrenia.

Authors:  Y Kawasaki; Y Maeda; K Urata; M Higashima; N Yamaguchi; M Suzuki; T Takashima; Y Ide
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

6.  Left superior temporal blood flow increases in schizophrenic and schizophreniform patients with auditory hallucination: a longitudinal case study using 123I-IMP SPECT.

Authors:  M Suzuki; S Yuasa; Y Minabe; M Murata; M Kurachi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

7.  Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.

Authors:  Scott A Schobel; Nashid H Chaudhury; Usman A Khan; Beatriz Paniagua; Martin A Styner; Iris Asllani; Benjamin P Inbar; Cheryl M Corcoran; Jeffrey A Lieberman; Holly Moore; Scott A Small
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

8.  The effect of distracting noise on the neuronal mechanisms of attention in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Lindsay Eichman; Donald C Rojas
Journal:  Schizophr Res       Date:  2012-10-09       Impact factor: 4.939

Review 9.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms.

Authors:  H Fukuzako; K Takeuchi; K Ueyama; T Fukuzako; Y Hokazono; K Hirakawa; K Yamada; T Hashiguchi; M Takigawa; T Fujimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.